by Five Rivers Rx | Oct 31, 2017 | Competition, Industry News, Uncategorized
Sitting down with executives from two multi-national brand drug companies, with market capitalization’s of $200 billion and $7.5 billion, we got a sneak-peek on market pressures and future strategies. Is Pfizer Selling Their Consumer Division for Cash...
by Five Rivers Rx | Oct 19, 2017 | Five Rivers
The Beginnings Two years ago, Five Rivers RX was born as a value-add for OpenRX, a self-proclaimed “Amazon of Pharmaceuticals” that would be a web-based platform for pharmacy buyers. An important aspect of OpenRX was that compliance was guaranteed for...
